Document Detail


Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.
MedLine Citation:
PMID:  20501764     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Serum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer.
AIMS: To determine whether serum adiponectin, leptin, C-peptide, and homocysteine are associated with fat, fiber, fruit and vegetable, flavonol, or dry bean intake and colorectal adenoma recurrence.
METHODS: Using logistic regression, we estimated odds ratios (OR) and 95% confidence intervals (95% CI) for adenoma recurrence in 627 participants from the control arm of the Polyp Prevention Trial, a 4-year trial that examined the effectiveness of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence.
RESULTS: Serum concentrations of C-peptide and homocysteine were inversely related to fiber, fruit and vegetable, and flavonol intake and positively related to percentage of calories from fat (all P(trend) < or = 0.01). High homocysteine concentrations were associated with any (4th versus 1st quartile: OR, 2.26; 95% CI, 1.30-3.94) and more than one adenoma recurrence (OR, 2.11; 95% CI, 1.01-4.40). Individuals in the highest, versus lowest, tertile of serum leptin concentration had a decreased risk of advanced adenoma recurrence (OR, 0.22; 95% CI, 0.06-0.79).
CONCLUSION: Our results suggest that serum homocysteine may serve as an indicator of dietary exposure, including a low-fat and high-fiber, high-fruit and vegetable, and high-flavonol diet, as well as colorectal adenoma recurrence.
IMPACT: Discovering biomarkers that are both modifiable and can predict cancer risk is critical. We identified serum homocysteine as a novel indicator that is modified by diet and predicts risk of adenoma recurrence.
Authors:
Gerd Bobe; Gwen Murphy; Connie J Rogers; Kenneth W Hance; Paul S Albert; Adeyinka O Laiyemo; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Related Documents :
3296944 - Nutritional aspects in oesophageal carcinogenesis (review).
18755044 - Effects of krill oil on serum lipids of hyperlipidemic rats and human sw480 cells.
3702444 - Free fatty acids: a possible regulator of the available oestradiol fractions in plasma.
8574864 - Is breast cancer avoidable? could dietary changes help?
3949734 - Metabolism of high density lipoproteins by the perfused rabbit liver.
21557284 - Analysis of the hydrogenotrophic microbiota of wild and captive black howler monkeys (a...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural     Date:  2010-05-25
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  19     ISSN:  1538-7755     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-09     Completed Date:  2010-10-15     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1441-52     Citation Subset:  IM    
Copyright Information:
Copyright 2010 AACR.
Affiliation:
Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute (NCI), NIH, Department of Health and Human Services (DHHS), Bethesda, Maryland, USA. gerd.bobe@oregonstate.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoma / blood*,  prevention & control
Adiponectin / blood
Adult
Aged
Aged, 80 and over
C-Peptide / blood
Colorectal Neoplasms / blood*,  prevention & control
Diet
Female
Follow-Up Studies
Homocysteine / blood
Humans
Leptin / blood
Male
Middle Aged
Neoplasm Recurrence, Local / blood*,  pathology
Recurrence
Risk Factors
Grant Support
ID/Acronym/Agency:
Z01 CN000151-19/CN/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Adiponectin; 0/C-Peptide; 0/Leptin; 454-28-4/Homocysteine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pigmentary Characteristics, UV Radiation Exposure, and Risk of Non-Hodgkin Lymphoma: a Prospective S...
Next Document:  "Future Directions in Cancer Prevention and Control: Workforce Implications for Training, Practice, ...